Clinical Trial Update: Oral Prednisolone in Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating oral prednisolone for severe acute exacerbation of chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Exacerbation of Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Prednisolone (Prednisolone)

Snippet

Sponsor: Fekri Abroug | Conditions: COPD Exacerbation | Phase 3 | Status: COMPLETED